Research Abstract
At the Beth Israel Deaconess Medical Center. I have witnessed the clinical benefits that immune therapies (such as high dose interleukin 2, ipilimumab, and PD-1:PD-L1 blocking agents) can have in my patients. My current research focus in the laboratory is to better understanding the biology of immune checkpoints in tumors and how to augment patients’ immune response to effectively attack their tumors.
